Michael S. Cuffe - May 6, 2024 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
EVP and Chief Clinical Officer
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
May 6, 2024
Transactions value $
-$1,782,683
Form type
4
Date filed
5/8/2024, 05:43 PM
Previous filing
Feb 21, 2024
Next filing
May 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Sale -$494K -1.6K -4.48% $309.00 34.1K May 6, 2024 Direct F1
transaction HCA Common Stock Options Exercise $2.59M +18.7K +54.68% $139.06 52.8K May 7, 2024 Direct F1
transaction HCA Common Stock Tax liability -$3.88M -12.3K -23.4% $314.45 40.4K May 7, 2024 Direct F1
transaction HCA Common Stock Gift $0 -4.5K -11.13% $0.00 35.9K May 8, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -18.7K -100% $0.00* 0 May 7, 2024 Common Stock 18.7K $139.06 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 2,463.9692 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
F2 The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020.